In the same way, ROS inhibit PKM2 (a cancer-expressed isoform of pyruvate kinase), leading to accumulation of glycolytic intermediates, which feed into the pentose phosphate pathway to generate NADPH. The gene discussed is PKM; the disease is cancer.